Table 1.
Clinical characteristics of the participants with regard to substance-related factors
| N | % | ||
|---|---|---|---|
| Main substance | Hash | 8 | 5.3% |
| Synthetic cannabinoids | 26 | 17.3% | |
| Tramadol | 18 | 12.0% | |
| Heroin | 71 | 47.3% | |
| Amphetamine | 1 | 0.7% | |
| Polysubstance | 22 | 14.7% | |
| Pregabalin | 3 | 2.0% | |
| Slcohol | 1 | 0.7% | |
| Max dose of heroin if it is the main substance | Less than 0.5 | 2 | 2.3% |
| 0.5–1 gm | 26 | 30.2% | |
| More than 1 gm | 58 | 67.4% | |
| Route of intake | Smoke | 35 | 23.3% |
| Injection | 49 | 32.7% | |
| Oral | 22 | 14.7% | |
| Multiple | 22 | 14.7% | |
| Sniffing | 22 | 14.7% | |
| Duration of abuse | 1–3 years | 2 | 1.3% |
| More than 3 years | 148 | 98.7% |